How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 01, 2020
Source ID
10.1016/j.comppsych.2020.152174

Entities

People

  • B. Dell'osso
  • C. Lochner
  • C.i. Rodriguez
  • D. Adam
  • D. Geller
  • D. Mpavaenda
  • D.j. Stein
  • D.j. Veltman
  • Eric Hollander
  • G. Grassi
  • H. Nicolini
  • J. Zohar
  • J.d. Feusner
  • J.m. Menchon
  • L. Carmi
  • L. Drummond
  • L. Pellegrini
  • L.f. Fontenelle
  • M. Van Ameringen
  • N. Sireau
  • N.a. Fineberg
  • P. Morgado
  • S. Pallanti
  • S. Walitza

Organizations

  • Angelini Holding
  • AstraZeneca
  • Bial
  • Biogen
  • Canada Foundation for Innovation
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • European College of Neuropsychopharmacology
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • GW Pharmaceuticals
  • Hoffmann-La Roche
  • Horizon 2020
  • Laboratoires Servier
  • Lundbeck
  • Medical Research Council
  • National Council for Scientific and Technological Development
  • National Institute for Health and Care Research
  • National Institute of Mental Health
  • Pfizer
  • Purdue Pharma
  • Seventh Framework Programme
  • Sun Microsystems
  • Swiss National Science Foundation
  • United States Department of Defense
  • University of Hertfordshire